Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/ki.2013.419 http://scihub22266oqcxt.onion/10.1038/ki.2013.419 24583980!3942788!24583980     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=24583980&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Kidney+Int 2014 ; 85 (3): 496-8 Nephropedia Template TP {{tp|p=24583980|t=2014. beta-Lapachone ameliorates murine cisplatin nephrotoxicity: NAD(+), NQO1, and SIRT1 at the crossroads of metabolism, injury, and inflammation |pdf=|usr=}}{{24583980}} gab.com Text beta-Lapachone ameliorates murine cisplatin nephrotoxicity: NAD(+), NQO1, and SIRT1 at the crossroads of metabolism, injury, and inflammation JO: Kidney Int http://www.kidney.de/pget.php?&tw=1&pmid=24583980 #FOAvip The clinical utility of cisplatin is limited by nephrotoxicity. Oh et al. report that beta-lapachone prevents this nephrotoxicity but not cisplatin's cytotoxicity for cancers. In addition to its potential clinical importance, the beneficial effect of beta-lapachone on cisplatin acute kidney injury may illustrate fundamental processes that ordinarily link alterations in nutrient availability and intracellular reactive oxygen species on the one hand, with inflammation and cell death on the other hand. Twit Text FOAVip beta-Lapachone ameliorates murine cisplatin nephrotoxicity: NAD(+), NQO1, and SIRT1 at the crossroads of metabolism, injury, and inflammation ????Kidney Int http://www.kidney.de/pget.php?&tw=1&pmid=24583980 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24583980 #FOAvip English Wikipedia <ref>{{Cite pmid|24583980}}</ref> beta-Lapachone ameliorates murine cisplatin nephrotoxicity: NAD(+), NQO1, and SIRT1 at the crossroads of metabolism, injury, and inflammation #MMPMID24583980 Lu CY Kidney Int 2014[Mar]; 85 (3): 496-8 PMID24583980show ga The clinical utility of cisplatin is limited by nephrotoxicity. Oh et al. report that beta-lapachone prevents this nephrotoxicity but not cisplatin's cytotoxicity for cancers. In addition to its potential clinical importance, the beneficial effect of beta-lapachone on cisplatin acute kidney injury may illustrate fundamental processes that ordinarily link alterations in nutrient availability and intracellular reactive oxygen species on the one hand, with inflammation and cell death on the other hand. |Acute Kidney Injury/*prevention & control[MESH] |Animals[MESH] |Antineoplastic Agents/*toxicity[MESH] |Cisplatin/*toxicity[MESH] |NAD(P)H Dehydrogenase (Quinone)/*physiology[MESH]beta-Lapachone ameliorates murine cisplatin nephrotoxicity: NAD(+), NQ(epmc).pdf DeepDyve Pubget Overpricing